Amphotericin BLEMKE, A; KIDERLEN, A. F; KAYSER, O et al.Applied microbiology and biotechnology. 2005, Vol 68, Num 2, pp 151-162, issn 0175-7598, 12 p.Article

A labile point in mutant amphotericin polyketide synthasesKHAN, Naseem; RAWLINGS, Bernard; CAFFREY, Patrick et al.Biotechnology letters. 2011, Vol 33, Num 6, pp 1121-1126, issn 0141-5492, 6 p.Article

Interactions between amphotericin B and sterols in monolayers. Mixed films of amphotericin B-cholesterolSEOANE, R; MINONES, J; CONDE, O et al.Langmuir. 1999, Vol 15, Num 17, pp 5567-5573, issn 0743-7463Article

Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different mediaVITALE, Roxana G; MEIS, Jacques F. G. M; MOUTON, Johan W et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 52, Num 1, pp 65-70, issn 0305-7453, 6 p.Article

Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin BDE AGUIAR CORDEIRO, R; MOURAO, C. I; ROCHA, M. F. G et al.European journal of clinical microbiology & infectious diseases (Print). 2013, Vol 32, Num 4, pp 557-564, issn 0934-9723, 8 p.Article

Efficacy of Pentavalent Antimony, Amphotericin B, and Miltefosine in Leishmania amazonensis-Infected Macrophages Under Normoxic and Hypoxic ConditionsAYRES, D. C; PINTO, L. A; GIORGIO, S et al.The Journal of parasitology. 2008, Vol 94, Num 6, pp 1415-1417, issn 0022-3395, 3 p.Article

Large-conductance cholesterol-amphotericin B channels in reconstituted lipid bilayersYILMA, Solomon; CANNON-SYKORA, Jennifer; SAMOYLOV, Alexandre et al.Biosensors & bioelectronics. 2007, Vol 22, Num 7, pp 1359-1367, issn 0956-5663, 9 p.Article

High purity amphotericin BCLEARY, John D; CHAPMAN, Stanley W; SWIATLO, Edwin et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 6, pp 1331-1340, issn 0305-7453, 10 p.Article

Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2RAZONABLE, Raymund R; HENAULT, Martin; LEE, Linda N et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1617-1621, issn 0066-4804, 5 p.Article

Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: Animal experiments and clinical studyMAYER, J; DOUBEK, M; DOUBEK, J et al.The Journal of infectious diseases. 2002, Vol 186, Num 3, pp 379-388, issn 0022-1899, 10 p.Article

Amphotéricine B : ancien médicament, nouveaux concepts = Amphotericin B: an old drug, new conceptsBOLARD, J; JOLY, V; YENI, P et al.MT. Médecine thérapeutique. 1997, Vol 3, Num 3, pp 207-213, issn 1264-6520Article

Nonspecific Effect of Mycograb on Amphotericin B MICRICHIE, D. L; GHANNOUM, M. A; ISHAM, N et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 7, pp 3963-3964, issn 0066-4804, 2 p.Article

Ultrashort Peptide Bioconjugates Are Exclusively Antifungal Agents and Synergize with Cyclodextrin and Amphotericin BARNUSCH, Christopher J; ULM, Hannah; JOSTEN, Michaele et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 1, pp 1-9, issn 0066-4804, 9 p.Article

Acute amphotericin B overdoseBURKE, Douglas; LAL, Rajiv; FINKEL, Kevin W et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 12, pp 2254-2259, issn 1060-0280, 6 p.Article

Lipid amphotericin B combinations; 'la crème de la crème'?HAY, R. J.The Journal of infection. 1999, Vol 39, Num 1, pp 16-20, issn 0163-4453Conference Paper

Structure-Antifungal Activity Relationships of Polyene Antibiotics of the Amphotericin B GroupTEVYASHOVA, Anna N; OLSUFYEVA, Evgenia N; ISAKOVA, Elena B et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 8, pp 3815-3822, issn 0066-4804, 8 p.Article

In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifoliaALI, Intzar; SHARMA, Punita; KRISHAN AVTAR SURI et al.Journal of medical microbiology. 2011, Vol 60, Num 9, pp 1326-1336, issn 0022-2615, 11 p.Article

Comparison of the Physicochemical, Antifungal, and Toxic Properties of Two Liposomal Amphotericin B ProductsOLSON, Jon A; ADLER-MOORE, Jill P; JENSEN, Gerard M et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 1, pp 259-268, issn 0066-4804, 10 p.Article

Favorable outcome of amphotericin B treatment of zygomycotic necrotizing fascitis caused by Apophysomyces elegansDEVI, Sheela C; KANUNGO, Reba; BARRETO, Elvino et al.International journal of dermatology. 2008, Vol 47, Num 4, pp 407-409, issn 0011-9059, 3 p.Article

Peptide stabilized amphotericin B nanodisksTUFTELAND, Megan; PESAVENTO, Joseph B; BERMINGHAM, Rachelle L et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 4, pp 741-746, issn 0196-9781, 6 p.Article

Effet du lavage nasal avec un antifongique, l'amphotéricine B, sur la polypose ethmoïdale = Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposisMAFFIOLI, A; RICCHETTI, A; LANDIS, B et al.Médecine et hygiène. 2001, Vol 59, Num 2364, pp 2005-2006, issn 0025-6749Article

Hypothernia following the intravenous administration of amphotericin BBARLOWS, T. G; LUBER, A. D; JACOBS, R. A et al.Clinical infectious diseases. 1996, Vol 23, Num 5, pp 1187-1188, issn 1058-4838Article

New high-performance liquid chromatographic method for amphotericin B analysis using an internal standardLAMBROS, M. P; ALI ABBAS, S; BOURNE, D. W. A et al.Journal of chromatography. Biomedical applications. 1996, Vol 685, Num 1, pp 135-140, issn 0378-4347Article

Amphotericin B: Time for a new gold standardOSTROSKY-ZEICHNER, Luis; MARR, Kieren A; REX, John H et al.Clinical infectious diseases. 2003, Vol 37, Num 3, pp 415-425, issn 1058-4838, 11 p.Article

A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin BCAPILLA, Javier; MAYAYO, Emilio; SERENA, Carolina et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 6, pp 1092-1095, issn 0305-7453, 4 p.Article